167 related articles for article (PubMed ID: 15577039)
1. [Biological activity of FGF-23 and pathophysiologic role in chronic kidney disease].
Yamashita T
Clin Calcium; 2004 May; 14(5):760-3. PubMed ID: 15577039
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
3. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
Shigematsu T; Kazama JJ; Yamashita T; Fukumoto S; Hosoya T; Gejyo F; Fukagawa M
Am J Kidney Dis; 2004 Aug; 44(2):250-6. PubMed ID: 15264182
[TBL] [Abstract][Full Text] [Related]
5. [Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
Goto S; Fukagawa M
Clin Calcium; 2009 Jun; 19(6):809-14. PubMed ID: 19483275
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
7. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
[TBL] [Abstract][Full Text] [Related]
8. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
Shimada T; Hasegawa H; Yamazaki Y; Muto T; Hino R; Takeuchi Y; Fujita T; Nakahara K; Fukumoto S; Yamashita T
J Bone Miner Res; 2004 Mar; 19(3):429-35. PubMed ID: 15040831
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Hu P; Xuan Q; Hu B; Lu L; Wang J; Qin YH
Int J Biol Sci; 2012; 8(5):663-71. PubMed ID: 22606047
[TBL] [Abstract][Full Text] [Related]
10. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
Isakova T; Gutierrez O; Shah A; Castaldo L; Holmes J; Lee H; Wolf M
J Am Soc Nephrol; 2008 Mar; 19(3):615-23. PubMed ID: 18216315
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056
[TBL] [Abstract][Full Text] [Related]
13. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
[TBL] [Abstract][Full Text] [Related]
14. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
[TBL] [Abstract][Full Text] [Related]
15. Hyperparathyroidism and renal failure.
Arnaud CD
Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
[No Abstract] [Full Text] [Related]
16. Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients.
Saki F; Kassaee SR; Salehifar A; Omrani GHR
BMC Nephrol; 2020 May; 21(1):176. PubMed ID: 32398014
[TBL] [Abstract][Full Text] [Related]
17. FGF-23 in patients with end-stage renal disease on hemodialysis.
Imanishi Y; Inaba M; Nakatsuka K; Nagasue K; Okuno S; Yoshihara A; Miura M; Miyauchi A; Kobayashi K; Miki T; Shoji T; Ishimura E; Nishizawa Y
Kidney Int; 2004 May; 65(5):1943-6. PubMed ID: 15086938
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.
Yamashita H; Yamashita T; Miyamoto M; Shigematsu T; Kazama JJ; Shimada T; Yamazaki Y; Fukumoto S; Fukagaw M; Noguchi S
Eur J Endocrinol; 2004 Jul; 151(1):55-60. PubMed ID: 15248822
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of FGF-23 in chronic kidney disease.
Seiler S; Heine GH; Fliser D
Kidney Int Suppl; 2009 Dec; (114):S34-42. PubMed ID: 19946326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
